动脉瘤性蛛网膜下腔出血治疗的争论 神经保护药和抗栓药的应用
被引量:4
Controversies in the Management of Aneurysmal Subarachnoid Hemorrhage The Application of Neuroprotective and Antithrombotic Agents
摘要
脑血管痉挛相关的脑缺血可通过积极治疗而得到预防甚至避免,出于这一设想,几十年来人们一直努力探索动脉瘤性蛛网膜下腔出血后脑保护的药物和方法,但结论始终难以统一,而且存在不少争论。文章就此进行了讨论。
出处
《国际脑血管病杂志》
2006年第8期633-636,共4页
International Journal of Cerebrovascular Diseases
参考文献23
-
1Naval NS,Stevens RD,Mirski MA,et al.Controversies in the management of aneurysmal subarachnoid hemorrhage.Crit Care Med,2006,34:511 -524.
-
2Rinkel GJ,Feigin VL,Algra A,et al.Calcium antagonists for aneurysmal subarachnoid haemorrhage.Cochrane Database Syst Rev,2005,(1):CD000277.
-
3Kasuya H,Onda H,Sasahara A,et al.Application of nicardipine prolonged-release implants:analysis of 97 consecutive patients with acute subarachnoid hemorrhage.Neurosurgery,2005,56:895 -902.
-
4Kassell NF,Haley EC Jr,Apperson-Hansen C,et al.Randomized,double-blind,vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage:a cooperative study in Europe,Australia,and New Zealand.J Neurosurg,1996,84:221 -228.
-
5Haley EC Jr,Kassell NF,Apperson-Hansen C,et al.A randomized,double-blind,vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage:a cooperative study in North America.J Neurosurg,1997,86:467 -474.
-
6Dorsch NW,Kassell NF,Sinkula MS.Meta-analysis of trials of tirilazad mesylate in anetysmal SAH.Acta Neurochir Suppl,2001,77:233-235.
-
7Poungvarin N.Steroids have no role in stroke therapy.Stroke,2004,35:229-230.
-
8Chyatte D,Fode NC,Nichols DA,et al.Preliminary report:effects of high dose methylprednisolone on delayed cerebral ischemia in patients at high risk for vasospasm after aneurysmal subarachnoid hemorrhage.Neurosurgery,1987,21:157-160.
-
9van den Bergh WM,Algra A,van Kooten F,et al.Magnesium sulfate in aneurysmal subarachnoid hemorrhage:a randomized controlled trial.Stroke,2005,36:1011-1015.
-
10Gupta VK.Magnesiun for delayed cerebral ischemia in aneurysmal subachnoid hemorrhage:time for a paradigm shift? Stroke,2005,36:2530.
同被引文献17
-
1黄波,高添喜,伍爱平,张雪平,雷飞跃,何民.重型颅脑损伤后脑性盐耗综合征诊治的探讨[J].中国医师杂志,2004,6(10):1341-1342. 被引量:10
-
2高宗恩,苏克江,冯兰玲.动脉瘤性蛛网膜下腔出血的治疗脑血管痉挛致迟发性脑缺血应如何诊断和处理?[J].国际脑血管病杂志,2006,14(7):552-555. 被引量:3
-
3沈健康.脑血管痉挛的机理和防治[J].中华脑血管病论坛,2006,3(1):19.
-
4梁琪,宋锦宁.SAH致脑血管痉挛的机制和临床治疗进展[J].国际脑血管病论坛,2002,14(6):441.
-
5黄如训.SAH 治疗的基本观点和措施[J].中华脑血管病论坛,2006,3(1):2.
-
6Spatenkova VK,Skrabalek PK,Suchomel P,et al.N-terminal pro-brain natriuretic peptide (NT-proBNP) in acute brain diseases:elevated serum levels in patients without sodium imbalance:P 004[J].European Journal of Anaesthesiology,2008,25 (Sup 43):2.
-
7Zakynthinos E,Kiropoulos T.Diagnostic and prognostic impact of brain natriuretic peptide in cardiac and noncardiac diseases[J].Heart and Lung:Journal of Acute Critical Care,2008,37(4):275-285.
-
8Makikallio AM,Makikallio TH,Korpelainen JT,et al.Natriuretic peptides and mortality after stroke[J].Stroke,2005,36:1016-1020.
-
9Uygun O,Ozkal E,Acar O,et al.Cerebral salt wasting syndrome[J].Neurosurg Rev,1996,19(3):193-196.
-
10Aaslid R,Huber P,Nornes H,et al.Evaluation of cerebrovascular spasm with transcranial Doppler ultrasound[J].J Neurosurg,1984,60:37-41.
引证文献4
-
1闫丽清,李英.蛛网膜下腔出血后迟发性脑缺血的临床观察[J].中国实用神经疾病杂志,2008,11(2):105-106. 被引量:4
-
2贾龙斌,庞书先,王国印,李改荣,杨丰兵,吕刚.蛛网膜下腔出血53例病因分析与处理[J].中西医结合心脑血管病杂志,2008,6(7):876-876.
-
3崔建仕.蛛网膜下腔出血50例病因分析[J].中国实用神经疾病杂志,2009,12(17):53-53.
-
4方志成,郑翔,刘伯毅,陈黎.重型颅脑损伤合并脑性耗盐综合征患者39例血浆脑型利钠肽浓度的变化[J].陕西医学杂志,2010,39(12):1614-1616. 被引量:1
二级引证文献5
-
1姜之荣.尼莫同治疗蛛网膜下腔出血后脑血管痉挛的疗效观察[J].中国实用神经疾病杂志,2009,12(7).
-
2曹梦云,李燕玲.动脉瘤性蛛网膜下腔出血后迟发性脑缺血的护理[J].第三军医大学学报,2010,32(17):1833-1833. 被引量:2
-
3樊继军,马彦,陈磊,杨晨.36例重症颅脑损伤低血钠综合征的治疗[J].宁夏医科大学学报,2011,33(7):673-674. 被引量:1
-
4郝彩江,毓青.蛛网膜下腔出血后迟发性脑缺血患者血清可溶性凝集素样氧化型低密度脂蛋白受体-1水平的变化及其意义[J].临床神经病学杂志,2012,25(5):373-374. 被引量:5
-
5金彦斌,丁哲旻,李江安,鲁晓杰.脑血流储备与蛛网膜下腔出血后迟发性脑缺血相关性的临床分析[J].临床神经外科杂志,2015,12(1):61-63. 被引量:4
-
1吴淑花,李丽娜,王桂荣.联合交替使用抗栓药治疗脑血栓形成20例临床观察[J].吉林医学,1993,14(2):121-121.
-
2王丽军.速避凝治疗急性脑梗塞48例[J].菏泽医学专科学校学报,2000,12(3):75-76.
-
3端木鲁健,端木青霞,冯子彦.低分子量肝素治疗急性脑梗塞疗效观察[J].中华综合临床医学杂志(北京),2005,7(11):47-48.
-
4赵燕,李慧明.低分子肝素治疗急性脑梗塞疗效及安全性观察[J].深圳医学,1999,12(4):37-37.
-
5曲东锋.既往脑缺血患者的脑出血风险预测因素[J].国际脑血管病杂志,2006,14(2):85-85.
-
6孙凯.依达拉奉在蛛网膜下腔出血治疗中的脑保护作用[J].中国现代药物应用,2012,6(23):16-17.
-
7刘芳.舒适护理对蛛网膜下腔出血患者的影响[J].吉林医学,2013,34(27):5728-5728. 被引量:6
-
8李高伟.尼莫地平在创伤性蛛网膜下腔出血治疗中的应用价值[J].深圳中西医结合杂志,2015,25(22):105-106. 被引量:3
-
9曹奕波,邰云飞,张振,黄玉杰.尼莫地平在创伤性蛛网膜下腔出血治疗中的临床疗效[J].中国医药科学,2014,4(22):64-66. 被引量:5
-
10莫国毅.用尼莫通预防蛛网膜下腔出血后脑血管痉挛[J].贵阳医学院学报,2002,27(5):421-422.